<p>The invention provides pharmaceutical compositions for the treatment or prevention of inflammatory diseases of intestine or chronic liver diseases. The compositions contain either products of the treatment of fermented whey with propionic acid bacterium, or 1,4-dihydroxy-2-naphthoic acid or salts thereof.</p>
